Schedule of Events


Saturday, April 26, 2014

 

8:30AM - 10:30AM
Travel Medicine: Self-treatment and Prevention

UAN: 0113-0000-14-557-L04-P

This program will give pharmacists a basic understanding of the range of conditions and medications they may now furnish under SB493.

At the completion of this activity, the participant will be able to:  1. Define the practice of travel medicine for pharmacists as a peer standard in California  2. Discuss the need for travel medicine services  3. Compare and contrast those conditions for which a diagnosis is not required vs. required  4. Review the conditions and medications that may be furnished under SB493

Jeff Goad, PharmD, MPH, USC, School of Pharmacy

 

New Drug Update 2014

UAN: 0113-0000-14-569-L01-P

This presentation considers the properties and uses of selected new therapeutic agents.  The indications and routes of administration for these new drugs are reviewed, as are the most important precautions and practical considerations regarding their use.  Where possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications.  A New Drug Comparison Rating (NDCR) is provided for each of the new drugs considered.

At the completion of this activity, the participant will be able to: 1. Identify the indications and routs of administration of the new therapeutic agents that were marketed in 2013. 2. Identify the important pharmacokinetic properties and unique characteristics of the new drugs. 3. Identify the most important adverse events and precautions of the new drugs. 4. Compare the new drugs to the older therapeutic agents to which they are most similar in activity. 5. Identify information regarding the new drugs that should be communicated to patients.

Dan Hussar, PhD, Philadelphia College of Pharmacy

 

Internal Pharmacy Security: Pharmacy Safety and Security - Institutional Diversion

UAN: 0113-0000-14-583-L04-P

This course is an overview of several types of pharmacy crimes and procedures to consider in preventing crime and deterring diversion.  This course will prepare the health care professional to evaluate the circumstances that surround the trends, patterns, and risk factors associated with pharmacy crime.  The participant will learn techniques to prevent and deter diversion, robberies and burglaries.  Also reviewed will be:  1. Securing the pharmacy: A review of intrusion detection systems, video surveillance/ camera placement, physical design and internal controls.  2. Techniques for appropriate response to a robbery or burglary  3. Techniques to become a good witness and protect your patients, employees and yourself during stressful situations such as: Robberies, Burglaries, Forged/Altered Prescriptions, Fraudulent Call in Prescriptions  4. Development of effective policies and procedures to address pharmacy crimes  5. Self-Evaluation Security Checklist will be discussed and provided to participants    The course will include case studies and discuss steps to prevent diversion within an institution.  The course is intended to address the “WHY, WHAT, WHO, HOW, & WHERE” of diversion of controlled substances and high value medications in an institutional setting also. The course focuses on legitimate access, developing strong policy and identifying sources of internal theft and diversion

Marc Gonzalez, PharmD

 

 2:30PM - 3:30PM

Pharmacy Ownership -  Buy or "Build"?

UAN: 0113-0000-14-554-L04-P

A discussion of the advantages and dis-advantages of buying or pioneering a pharmacy.  Review the process of buying a pharmacy and review the process of  opening a new pharmacy.

At the completion of this activity, the participant will be able to: 1. Compare the advantages and dis-advantages of buying a pharmacy versus opening a new pharmacy.  2. Understand the process of buying a pharmacy.  3. Understand the process of opening a new pharmacy.

Terry Cater, R.Ph., M.B.A.

 

2:30PM - 5:30PM


Contraception "Boot Camp" for the Pharmacist

Sponsored by Cardinal Health
UAN: 0113-0000-14-570-L04-P

This presentation will be broken out into two sessions.

First 1.5 hours “Contraception 101:”

This session will provide a general overview of contraceptive methods, “hot-off-the-press” clinical updates and discuss the CDC Medical Eligibility Criteria for Contraception.   This session will be applicable to a broad audience and focus on contraception methods (what’s new, what’s changed, and trends) and introduce the MEC.

At the completion of this activity, the participant will be able to: 1.
Compare the currently available methods of contraception (pills, patches, ring, implants, intra-uterine devices and barriers) with respect to mechanism of action, efficacy, side effects and safety. 2. Describe the most recent and developing contraceptive options for patients in the United States. 3. Explain the proper use of contraceptives to men/women seeking advice from the pharmacist.  4. Assist men and women in the selection of a contraceptive that meets their individual needs.


Second 1.5 hours “Providing Hormonal Contraceptives in the Pharmacy: SB493: A How to Guide for Pharmacists”

This session will be applicable to pharmacists interested in providing hormonal contraceptive services to women applying the newly passed SB-493 protocol. The sessions will be case-based.  Participants will be provided the tools for providing HC services and work through cases using the US-MEC and a self-screening tool. The session will be interactive and practical.

At the completion of this activity, the participant will be able to: 1. Describe the requirements for providing hormonal contraceptives under the provisions of SB-493. 2. Utilize a self-screening tool to identify women in whom hormonal contraception is appropriate. 3. Apply the US-MEC criteria to determine the suitability for pharmacist initiated hormonal contraception. 4. Provide up to date evidence based contraceptive care in a pharmacy setting.

Kathy Besinque, PharmD, University of Southern California

Sarah McBane, PharmD, UCSD Skaggs School of Pharmacy

 

Pharmacists Role in the Health Care System Post ACA & How to Engage Individual Pharmacists in Political Advocacy

UAN: 0113-0000-14-573-L03-P

The Affordable Care Act and changes to California’s Pharmacy Practice Act has created new opportunities for pharmacists.  This program will discuss some opportunities for individual pharmacists to become more involved in direct patient care initiatives, including those which allow pharmacists to operate as a primary care provider.  In addition, the program will discuss ways pharmacists can become more active in advocating for change both within healthcare systems and in the development of innovative health policies.  Lastly, the relationship between the state’s provider status law and federal efforts to garnish pharmacists provider status within Medicare regulations will be discussed.

At the completion of this activity, the participant will be able to:  1. Describe techniques for individual pharmacists to use to develop innovative patient care opportunities within their healthcare systems.    2. Explain the importance of the connection between state and federal provider status.    3. Discuss the need for individual pharmacist involvement in health policy initiatives and techniques to achieve this.

Daniel Tomaszewski, PharmD, PhD Candidate, University of Minnesota, College of Pharmacy

 

2:45PM - 3:45PM

Bridge the Gap: Connecting Student Pharmacists to Potential Employers

UAN: 0113-0000-14-580-L04-P

One of the best ways to find a pharmacy job is through a direct connection with the person in charge of hiring. CPhA wants to provide you the opportunity to interact with pharmacy owners, company recruits, and other potential employers who may someday greatly impact your pharmacy career. This programming will facilitate interactions that will resemble an interview process, but will be more open to bilateral discussion between potential employees and employers with the intention of developing a strong connection between both parties.


At the completion of this activity, the participant will be able to: 1. Introduce new graduate and student pharmacists to compounding pharmacy  2. Connect attendees through a shared discussion of mutual interests  3. Solidify CPhA's role in supporting compounding pharmacy's growth  4. Network building

Kalsang Dorji, PharmD, ITL Consulting

 

3:45PM - 4:45PM

Update on Hypertension

UAN: 0113-0000-14-582-L04-P

Nathan Painter, PharmD, CDE, University of California, San Diego

 

4:00PM - 5:00PM

Pharmacy Ownership 101 - A Step-By-Step on How to Open an Independent Pharmacy

UAN: 0113-0000-14-576-L04-P

Do you want to open your own Pharmacy?  Come discover the exact steps, from the very beginning to the day you open your doors for business.  If you have a brilliant pharmacy concept, we will show you the legal, administrative, and practical considerations that must fulfilled.

At the completion of this activity, the participant will be able to:  1.Recognize the different types of pharmacy ownership in California.  2.Distinguish between local, state, and federal requirements of a pharmacy business.  3.Construct an action plan to conform with all of these requirements.  4.Identify common pitfalls experienced by new would-be pharmacy owners.

Tony Park, PharmD, J.D., California Pharmacy Lawyers

 

5:00PM - 6:00PM

Quality Assurance in Compounding: Why Can’t We Get This Right?

Sponsored by PCCA

UAN: 0113-0000-14-579-L04-P

Does your pharmacy do a little compounding or a lot? How do you know if your Quality Assurance program is adequate for your compounding practice?  This presentation will address these questions and many more.  Learn what areas are most over looked and how you can be confident that “You Have it Right” when your inspector reviews your quality assurance program.

At the completion of this activity, the participant will be able to:

1. Describe the purpose of a quality assurance program. 2. Discuss the most frequently over looked areas of quality assurance in a pharmacy that compounds. 3. Demonstrate through polling the major areas of concern in establishing a viable quality assurance program. 4. Discuss relationship of a viable quality assurance program as it relates to the California State Board of Pharmacy Regulations

Jerra Banwarth, BSP, PCCA Pharmacy Consultant

Chris Simmons, RPh, Creative Development

 

Update on Cholesterol Guidelines

UAN: 0113-0000-14-581-L04-P

Eric Gupta, PharmD, Western University of Health Sciences





Exchange Attendees: Click Here to Download CE Session Handouts

Onsite registration is available. Registration desk opens at 7:00am on Thursday, April 24.
 



Thank You to Our Sponsors: